Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ÄIO has developed a proprietary fermentation process using engineered yeast strains to convert industrial side streams (e.g., sawdust sugars, dairy waste) into sustainable fats and oils. The company has three main product lines—encapsulated oil, red oil, and buttery fats—targeting the replacement of palm oil, coconut fat, and animal fats in food products. Their technology reduces land use by up to 97% and water consumption by up to tenfold compared to conventional methods. They have secured €6.1M in funding for scaling up with a demonstration plant expected operational by 2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ÄIO.